Target intelligence / Profile preview

TIMP metallopeptidase inhibitor 3 (TIMP-3)

Target
TIMP-3
Molecular classification
Enzyme inhibitor (specifically a tissue inhibitor of metalloproteinases), Extracellular matrix protein
01

Overview

TIMP metallopeptidase inhibitor 3 is an extracellular protein encoded by the *TIMP3* gene. It belongs to the tissue inhibitors of metalloproteinases family and functions primarily as an endogenous regulator that inhibits various matrix metalloproteinases involved in extracellular matrix degradation. The protein is enriched in placenta and fat tissues and localizes within the extracellular space. Its expression can be induced by mitogenic stimulation. Mutations in *TIMP3* are associated with Sorsby fundus dystrophy, an autosomal dominant disorder affecting vision. The protein exists both unglycosylated (~24 kDa) and glycosylated (~29 kDa) forms with inhibitory activity against several MMPs including interstitial collagenase, stromelysin-1, gelatinase A, and gelatinase B[1][2][6].

Other names
Metalloproteinase inhibitor 3Tissue inhibitor of metalloproteinases 3Protein MIG-5SFD (Sorsby fundus dystrophy-associated protein)
02

Mechanism of action

No drugs are currently known to directly target or modulate TIMP metallopeptidase inhibitor 3 as a primary mechanism; however, its inhibition or upregulation may be influenced by indirect mechanisms in disease contexts.

03

Biological functions

Inhibition of matrix metalloproteinases (MMPs)Regulation of extracellular matrix degradationModulation of angiogenesisResponse to mitogenic stimulation
04

Disease associations

Sorsby fundus dystrophyFundus dystrophyPre-eclampsia (elevated circulating levels noted)Potential roles in cancer and cardiovascular disease due to MMP regulation and angiogenesis effects
05

Biomarkers

TIMP metallopeptidase inhibitor 3 itself is sometimes measured as a biomarker in certain conditions such as pre-eclampsia and possibly other diseases involving extracellular matrix remodeling or angiogenesis

Beyond the preview

Go deeper on TIMP metallopeptidase inhibitor 3 (TIMP-3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TIMP metallopeptidase inhibitor 3 (TIMP-3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call